(Q43955396)

English

Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

8

object named as

Helmut Friess

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Arno Kornberg

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Bernadett Küpper

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Andrea Tannapfel

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Peter Büchler

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Babette Krause

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ulrike Witt

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dietmar Gottschild

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

53-61

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Current controversies surrounding liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Positron emission tomography imaging in oncology

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

The value of positron emission tomography (PET) imaging in disease staging and therapy assessment

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Current status and future of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Seeding risk following percutaneous approach to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Benefit of downsizing hepatocellular carcinoma in a liver transplant population

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FLT.22416

21 January 2018

Identifiers

10.1002/LT.22416

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43955396&oldid=2104629300"